## 4 Bioactive Properties
### Antitumor Effects
\begin{table}
\begin{tabular}{c c c c c} \hline \hline
**Names** & **No.** & **Cell Lines** & **IC\({}_{\text{90}}\) (uM)** & **References** \\ \hline Fekolone & **187** & AGS & \(75.4\pm 2.1\) & [128] \\ \hline Fekrynol & **211** & HeLa & \(35\pm 0.6\) & [189] \\  & & MGC-803 & \(49\pm 0.8\) & [189] \\  & & AGS & \(20\pm 0.5\) & [189] \\ \hline Fekrynol acetate & **212** & HeLa & \(25\pm 0.6\) & [189] \\  & & MGC-803 & \(28\pm 1.2\) & [189] \\ \hline \multirow{4}{*}{(+)-Ferulasin} & \multirow{4}{*}{**422**} & PANC-1 & \(2.24\pm 0.83\) & [195] \\  & & CPAC-1 & \(6.12\pm 0.52\) & [195] \\  & & SW1990 & \(11.77\pm 1.57\) & [195] \\  & & Capan-2 & \(8.57\pm 0.59\) & [195] \\ \hline \multirow{2}{*}{(-)-Ferulasin} & \multirow{2}{*}{**423**} & PANC-1 & \(0.92\pm 0.12\) & [195] \\  & & CPAC-1 & \(19.13\pm 2.99\) & [195] \\ \hline \multirow{2}{*}{Feselol} & \multirow{2}{*}{**268**} & COLO205 & \(38.41\pm 0.8\) & [246] \\  & & MCF-7 & \(35.95\pm 1.29\) & [246] \\ \hline \multirow{2}{*}{Galbanic acid} & \multirow{2}{*}{**213**} & HeLa & \(43\pm 2.0\) & [189] \\  & & MCF-7 & \(56.65\pm 1.4\) & [225] \\  & & MDA-MB-231 & \(48.75\pm 1.16\) & [225] \\ \hline \(4^{\prime}\)-Hydroxy kamolonol acetate & **277** & HeLa & \(4.5\pm 0.1\) & [158] \\ \hline \multirow{2}{*}{13-Hydroxyfeselol} & \multirow{2}{*}{**271**} & HCT116 & \(34.1\pm 2.3\) & [75] \\  & & HT-29 & \(35.4\pm 4.0\) & [75] \\ \hline \multirow{2}{*}{Kamolonol} & \multirow{2}{*}{**334**} & HeLa & \(3.8\pm 0.1\) & [158] \\ \hline \multirow{2}{*}{Kellerin} & \multirow{2}{*}{**321**} & HeLa & \(37\pm 1.8\) & [189] \\  & & MCF-7 & \(18.24\pm 0.12\) & [246] \\ \hline \multirow{2}{*}{Lehmannolololol} & \multirow{2}{*}{**300**} & HeLa & \(42\pm 0.9\) & [189] \\  & & AGS & \(26.0\pm 0.9\) & [189] \\ \hline \multirow{2}{*}{Lehmannolone} & \multirow{2}{*}{**298**} & HeLa & \(81.1\pm 1.4\) & [128] \\ \hline \multirow{2}{*}{Mogoltadone} & \multirow{2}{*}{**227**} & COLO205 & \(31.71\pm 0.15\) & [246] \\  & & MCF-7 & \(30.45\pm 0.6\) & [246] \\  & & K-562 & \(21.11\pm 0.85\) & [246] \\  & & HepG2 & \(23.06\) & [247] \\ \hline \multirow{2}{*}{Polyanthinin} & \multirow{2}{*}{**226**} & HeLa & \(28\pm 0.4\) & [189] \\  & & MGC-803 & \(45\pm 0.9\) & [189] \\  & & AGS & \(45\pm 0.9\) & [189] \\ \hline \multirow{2}{*}{Sinkiangenol E} & \multirow{2}{*}{**222**} & HeLa & \(16\pm 0.8\) & [189] \\ \hline \multirow{2}{*}{Sinkiangenone A} & \multirow{2}{*}{**448**} & CMC-803 & \(45.05\pm 3.09\) & [21] \\  & & AGS & \(48.13\pm 0.87\) & [21] \\ \hline \multirow{2}{*}{Sinkiangenone B} & \multirow{2}{*}{**449**} & CMC-803 & \(18.89\pm 1.32\) & [21] \\  & & AGS & \(16.15\pm 0.14\) & [21] \\ \hline \multirow{2}{*}{Sinkiangenorin D} & \multirow{2}{*}{**219**} & HeLa & \(20.4\pm 1.3\) & [128] \\  & & AGS & \(104.8\pm 1.2\) & [128] \\  & & K562 & \(81.1\pm 1.0\) & [128] \\ \hline \multirow{2}{*}{Sinkiangenorin E} & \multirow{2}{*}{**344**} & AGS & \(12.7\pm 2.5\) & [30] \\ \hline \multirow{2}{*}{Sinkiangenorin F} & \multirow{2}{*}{**208**} & AGS & \(27.1\pm 1.4\) & [81] \\ \hline \multirow{2}{*}{Sinkianone} & \multirow{2}{*}{**201**} & HeLa & \(77.9\pm 0.7\) & [128] \\ \hline \multirow{2}{*}{Umbelliprenin} & \multirow{2}{*}{**150**} & AGS & \(11.74\pm 1.33\) & [193] \\  & & BGC-823 & \(24.62\pm 2.45\) & [193] \\  & & M4 Beu & \(12.4\) & [232] \\  & & BxPC3 & \(45.15\pm 2.57\) & [230] \\  & & PANC-1 & \(47.13\pm 5.13\) & [230] \\ \hline \hline \end{tabular}
\end{table} 
Table 6: _Cont._